Learn about critical drug-drug interactions involving direct acting antivirals (DAAs) used in hepatitis C treatment through this 34-minute educational webinar presented by clinical pharmacist Rachel Mitchell, PharmD, BCPS, CSP. Explore the most frequently encountered medication interactions that can occur when DAAs are prescribed alongside other commonly used drugs, understanding the clinical significance and management strategies for these interactions. Gain insights into how to identify potential drug interactions before initiating DAA therapy, assess the severity of interactions, and implement appropriate monitoring or dosage adjustments to ensure safe and effective hepatitis C treatment outcomes.